Early research shows new blood test can help predict testicular cancer recurrence
Medical Xpress
March 4, 2026
A new study co-led by WEHI has found a simple blood test can help identify the early-stage testicular cancer patients who are most at-risk of cancer relapse. The CLIMATE study found a protein, which is released into the bloodstream by testicular cancer cells, could detect tiny amounts of remaining cancer after surgical removal of the testicle.
Verticals
healthmedical
Originally published on Medical Xpress on 3/4/2026